Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Deutsche Bank stuft Aktie von AMG Critical Materials auf "Kaufen" hoch (Investing.com DE) +++ AMG CRITICAL Aktie +4,13%

GRAIL INC Aktie

 >GRAIL INC Aktienkurs 
42 EUR    -7.5%    (TradegateBSX)
Ask: 43.8 EUR / 100 Stück
Bid: 41.9 EUR / 100 Stück
Tagesumsatz: 143 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
GRAIL INC Aktie über LYNX handeln
>GRAIL INC Performance
1 Woche: +6,6%
1 Monat: -48,5%
3 Monate: -47,7%
6 Monate: +65,1%
1 Jahr: +32,7%
laufendes Jahr: -39,5%
>GRAIL INC Aktie
Name:  GRAIL INC. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US3847471014 / A40F8M
Symbol/ Ticker:  NL0 (Frankfurt) / GRAL (NASDAQ)
Kürzel:  FRA:NL0, ETR:NL0, NL0:GR, NASDAQ:GRAL
Index:  -
Webseite:  https://grail.com/
Profil:  Grail Inc. is a biotechnology company focused on the innovative field of early cancer detection testing. Its primary function is to develop and commercialize blood tests that enable the early detectio..
>Volltext..
Marktkapitalisierung:  1769.48 Mio. EUR
Unternehmenswert:  1040.35 Mio. EUR
Umsatz:  126.93 Mio. EUR
EBITDA:  -326.85 Mio. EUR
Nettogewinn:  -352.19 Mio. EUR
Gewinn je Aktie:  -9.64 EUR
Schulden:  47.32 Mio. EUR
Liquide Mittel:  215.38 Mio. EUR
Operativer Cashflow:  -257.89 Mio. EUR
Bargeldquote:  11.35
Umsatzwachstum:  3.28%
Gewinnwachstum:  82.24%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.214.509 USD.
Suchwörter:  GRAIL INC, GRAIL INCORPORATED, NASDAQ:GRAL
Letzte Datenerhebung:  04.03.26
>GRAIL INC Kennzahlen
Aktien/ Unternehmen:
Aktien: 38.98 Mio. St.
Frei handelbar: 89.84%
Rückkaufquote: -
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Buy
Kursziel: 83.92%
Bewertung:
KGV: -
KGV lG: -
KUV: 14.62
KBV: 0.79
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -50.54%
Gewinnmarge: -277.47%
Operative Marge: -362.97%
Managementeffizenz:
Gesamtkaprendite: -13.47%
Eigenkaprendite: -16.07%
>GRAIL INC Peer Group
Gesundheit, Onkologie/ Krebs- Behandlung
 
04.03.26 - 05:02
Insiderhandel: Chief Executive Officer verkauft Aktien von GRAIL im Wert von 1881417 USD (Insiderkauf)
 
Ragusa, Robert P. - Vorstand - Tag der Transaktion: 2026-03-02...
04.03.26 - 05:02
Insiderhandel: Chief Financial Officer verkauft Aktien von GRAIL im Wert von 480244 USD (Insiderkauf)
 
Freidin, Aaron - Vorstand - Tag der Transaktion: 2026-03-02...
04.03.26 - 05:02
Insiderhandel: President verkauft Aktien von GRAIL im Wert von 852848 USD (Insiderkauf)
 
Ofman, Joshua J. - Vorstand - Tag der Transaktion: 2026-03-02...
02.03.26 - 22:03
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
 
MENLO PARK, Calif., March 2, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of......
24.02.26 - 22:06
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference (PR Newswire)
 
MENLO PARK, Calif., Feb. 24, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 46th Annual Health Care Conference in Boston on Tuesday,......
24.02.26 - 14:13
GRAL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into GRAIL, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm (PR Newswire)
 
SAN DIEGO, Feb. 24, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving GRAIL, Inc. (NASDAQ: GRAL). If you have information that could assist in the GRAIL investigation or if you are a GRAIL......
16.02.26 - 15:03
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
 
MENLO PARK, Calif., Feb. 16, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter and full year 2025 following the close of market on......
30.01.26 - 01:27
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test (PR Newswire)
 
FDA Submission Marks a Pivotal Milestone in Advancing Early Cancer Detection, Addressing Unmet Needs in Cancer Screening MENLO PARK, Calif., Jan. 29, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today......
15.12.25 - 22:06
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
 
MENLO PARK, Calif., Dec. 15, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on......
06.12.25 - 02:01
Insiderhandel: President verkauft Aktien von GRAIL im Wert von 1300000 USD (Insiderkauf)
 
Ofman, Joshua J. - Vorstand - Tag der Transaktion: 2025-12-03...
06.12.25 - 02:01
Insiderhandel: Chief Executive Officer verkauft Aktien von GRAIL im Wert von 3809535 USD (Insiderkauf)
 
Ragusa, Robert P. - Vorstand - Tag der Transaktion: 2025-12-03...
06.12.25 - 02:01
Insiderhandel: Chief Financial Officer verkauft Aktien von GRAIL im Wert von 2478818 USD (Insiderkauf)
 
Freidin, Aaron - Vorstand - Tag der Transaktion: 2025-12-03...
01.12.25 - 22:03
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
 
MENLO PARK, Calif., Dec. 1, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of......
20.11.25 - 02:02
Insiderhandel: Chief Financial Officer verkauft Aktien von GRAIL im Wert von 134402 USD (Insiderkauf)
 
Freidin, Aaron - Vorstand - Tag der Transaktion: 2025-11-17...
19.11.25 - 06:02
Insiderhandel: Insider verkauft Aktien von GRAIL im Wert von 79850000 USD (Insiderkauf)
 
Illumina, Inc. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-11-17...
18.11.25 - 22:06
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference (PR Newswire)
 
MENLO PARK, Calif., Nov. 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, Dec. 2......
04.11.25 - 22:06
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference (PR Newswire)
 
MENLO PARK, Calif., Nov. 4, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18......
20.10.25 - 12:33
GRAIL, Inc. Announces $325.0 Million Private Placement Financing (PR Newswire)
 
MENLO PARK, Calif., Oct. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has entered into a securities purchase agreement for a private placement that is expected to result in......
17.10.25 - 03:01
Insiderhandel: Chief Executive Officer verkauft Aktien von GRAIL im Wert von 498622 USD (Insiderkauf)
 
Ragusa, Robert P. - Vorstand - Tag der Transaktion: 2025-10-15...
17.10.25 - 03:01
Insiderhandel: President verkauft Aktien von GRAIL im Wert von 673985 USD (Insiderkauf)
 
Ofman, Joshua J. - Vorstand - Tag der Transaktion: 2025-10-15...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer ein blindes Pferd verkaufen will, lobt die Füße. - Bauernregel - Bauernweisheit
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!